Cardinal Health Purchases The Harvard Drug Group For $1.115 Billion By: Benzinga via Benzinga June 05, 2015 at 08:17 AM EDT Cardinal Health Inc (NYSE: CAH) has agreed to purchase The Harvard Drug Group, a privately held generics company, in a deal valued at ... Read More >> Related Stocks: AmerisourceBergen Corp Cardinal Health Macy's McKesson Corp Prestige Brand Holdings